Kinetics of β -2-Microglobulin with Hemodiafiltration and High-Flux Hemodialysis.

Clin J Am Soc Nephrol

Division of Nephrology, Department of Medicine, University of Illinois College of Medicine, Chicago, Illinois.

Published: July 2024

Key Points: Addition of hemodiafiltration has a relatively small impact on reducing either predialysis or time-averaged serum -2-microglobulin levels. Residual kidney function has a major impact on the predialysis and time-averaged serum -2-microglobulin levels.

Background: A kinetic model for -2-microglobulin removal and generation was used to explore the impact of adding hemodiafiltration on predialysis and time-averaged serum values.

Methods: The model was tested on data from the HEMO study and on a sample of patients undergoing high-flux hemodialysis. The impact of hemodiafiltration on -2-microglobulin levels was evaluated by modeling four randomized studies of hemodiafiltration versus hemodialysis. The impact of residual kidney function on -2-microglobulin was tested by comparing results of previously reported measured data with model predictions.

Results: In the low-flux and high-flux arms of the HEMO study, measured median -2-microglobulin reduction ratios could be matched by dialyzer clearances of 5.9 and 29 ml/min, respectively. Median predialysis serum -2-microglobulin levels were matched if generation rates of -2-microglobulin were set to approximately 235 mg/d. In another group of patients treated with dialyzers with increased -2-microglobulin clearances, measured cross-dialyzer clearances (57±28 ml/min) were used as inputs. In these studies, the kinetic model estimates of intradialysis and early postdialysis serum -2-microglobulin levels were similar to median measured values. The model was able to estimate the changes in predialysis serum -2-microglobulin in each of four published randomized comparisons of hemodiafiltration with hemodialysis, although the model predicted a greater decrease in predialysis serum -2-microglobulin with hemodiafiltration than was reported in two of the studies. The predicted impact of residual kidney clearance on predialysis serum -2-microglobulin concentrations was similar to that reported in one published observational study. Modeling predicted that postdilution hemodiafiltration using 25 L/4 hours replacement fluid would lower serum time-averaged concentration of -2-microglobulin by about 18.2%, similar to the effect of 1.50 ml/min residual kidney GFR.

Conclusions: A two-pool kinetic model of -2-microglobulin yielded values of reduction ratio and predialysis serum concentration that were consistent with measured values with various hemodiafiltration and hemodialysis treatment regimens.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11254023PMC
http://dx.doi.org/10.2215/CJN.0000000000000461DOI Listing

Publication Analysis

Top Keywords

serum -2-microglobulin
28
predialysis serum
20
-2-microglobulin levels
16
residual kidney
16
-2-microglobulin
15
predialysis time-averaged
12
time-averaged serum
12
kinetic model
12
serum
10
hemodiafiltration
9

Similar Publications

Article Synopsis
  • The study examined the relationship between serum levels of 25-hydroxyvitamin D, IGF-1, and beta-2 microglobulin in elderly patients with cognitive dysfunction after ischemic stroke.
  • Data from 160 geriatric patients were analyzed, revealing that lower levels of 25-OH-VD and IGF-1 were linked to worse cognitive scores, while higher β2-MG levels correlated with greater cognitive decline.
  • Factors such as diabetes, low education levels, age, and certain serum markers were identified as independent risk factors for developing cognitive dysfunction post-stroke, suggesting the importance of monitoring these serum levels in clinical settings.
View Article and Find Full Text PDF

Aims: Serum creatinine and albuminuria are the core of most CKD prediction and progression risk models. Several biomarkers have been introduced to improve these results such as beta-2-microglobulin (B2M) and cystatin C (CysC). Nevertheless, few clinical comparisons of these biomarkers are available.

View Article and Find Full Text PDF
Article Synopsis
  • * Data from 203 patients from phase I/II clinical trials were used, creating both longitudinal and PFS-specific models that were then integrated into a joint model to capture their interactions.
  • * The final model indicated that serum M-protein changes correlate with PFS and validated the dosing regimen of Isa in a pivotal phase III study, supporting ongoing research and treatment approaches in multiple myeloma. *
View Article and Find Full Text PDF

: One of the most critical problems regarding sarcopenia is the difficulty of the diagnosis process. This study aimed to determine the prevalence and investigate the role of serum beta-2 microglobulin level as a biomarker for diagnosing sarcopenia. : This nested case-control study was conducted between 2023 and 2024 on 251 older adults.

View Article and Find Full Text PDF

Background: Plasma cell dyscrasias encompass a diverse set of disorders, where early and precise diagnosis is essential for optimizing patient outcomes. Despite advancements, current diagnostic methodologies remain underutilized in applying artificial intelligence (AI) to routine laboratory data. This study seeks to construct an AI-driven model leveraging standard laboratory parameters to enhance diagnostic accuracy and classification efficiency in plasma cell dyscrasias.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!